This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Can CT Enteroclysis Predict the Outcome of Crohn's Disease

This study has been completed.
Information provided by (Responsible Party):
Indiana University Identifier:
First received: December 11, 2007
Last updated: August 7, 2015
Last verified: August 2015
Specific CT Enteroclysis findings with or without other clinical and laboratory variables, can identify Crohn's disease patients who will response to medical therapy versus those who will either fail and require surgery or have uncontrolled disease.

Crohn's Disease

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Can CT Enteroclysis Predict the Response to Therapy and Outcome in Patient With Crohn's Disease

Resource links provided by NLM:

Further study details as provided by Indiana University:

Enrollment: 125
Study Start Date: August 2007
Study Completion Date: January 2012
Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
CTE with CD
Crohn's disease patients who underwent a CT enteroclysis as part of their clinical evaluation for symptomatic Crohn's disease.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Crohn's disease patients that have had a CT Enteroclysis as part of their clinical evaluation for symptomatic Crohn's disease will be eligible. Subjects who were later diagnosied with bowel malignancy and subjects with a period of follow-up of less than 1 year(without surgery) will be excluded.

Inclusion Criteria:

  • Crohn's disease with CT Enteroclysis during symptomatic treatment

Exclusion Criteria:

  • Crohn's disease subjects who have had a follow-up less than 1 year, without surgery
  • Crohn's disease subjects that were later diagnosed with a bowel malignancy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00572780

United States, Indiana
Indiana University
Indianapolis, Indiana, United States, 46202
Sponsors and Collaborators
Indiana University
Principal Investigator: Michael V. Chiorean, M.D. Indiana University
  More Information

Responsible Party: Indiana University Identifier: NCT00572780     History of Changes
Other Study ID Numbers: 070759
Study First Received: December 11, 2007
Last Updated: August 7, 2015

Keywords provided by Indiana University:
Crohn's Disease
CT Enteroclysis

Additional relevant MeSH terms:
Crohn Disease
Inflammatory Bowel Diseases
Gastrointestinal Diseases
Digestive System Diseases
Intestinal Diseases processed this record on September 19, 2017